These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 6459762
1. Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain. Komatsu Y, Murakami K, Nishikawa T. Antimicrob Agents Chemother; 1981 Nov; 20(5):613-9. PubMed ID: 6459762 [Abstract] [Full Text] [Related]
2. Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12. Komatsu Y, Nishikawa T. Antimicrob Agents Chemother; 1980 Mar; 17(3):316-21. PubMed ID: 6448573 [Abstract] [Full Text] [Related]
3. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins. Mouton RP, Bongaerts GP, van Gestel M, Bruggeman-Ogle KM. Chemotherapy; 1981 Mar; 27(5):318-24. PubMed ID: 6455258 [Abstract] [Full Text] [Related]
7. Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis. Yotsuji A, Minami S, Kakizawa H, Yasuda T, Takai A, Saikawa I, Inoue M, Mitsuhashi S. Antimicrob Agents Chemother; 1985 Dec; 28(6):773-7. PubMed ID: 3878690 [Abstract] [Full Text] [Related]
9. Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site. Trehan I, Beadle BM, Shoichet BK. Biochemistry; 2001 Jul 10; 40(27):7992-9. PubMed ID: 11434768 [Abstract] [Full Text] [Related]
10. [Moxalactam: an inactivator of beta-lactamases]. Labia R. Sem Hop; 1983 Jun 30; 59(26):1959-62. PubMed ID: 6310786 [Abstract] [Full Text] [Related]
11. Moxalactam: the first of a new class of beta-lactam antibiotics. Webber JA, Yoshida T. Rev Infect Dis; 1982 Jun 30; 4 Suppl():S496-500. PubMed ID: 6218558 [Abstract] [Full Text] [Related]
16. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. Schaad UB, McCracken GH, Loock CA, Thomas ML. J Infect Dis; 1981 Feb 30; 143(2):156-63. PubMed ID: 6260870 [Abstract] [Full Text] [Related]
17. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity. Murakami K, Yoshida T. Antimicrob Agents Chemother; 1981 Jan 30; 19(1):1-7. PubMed ID: 6454378 [Abstract] [Full Text] [Related]
18. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics. Chan PH, Chan KC, Liu HB, Chung WH, Leung YC, Wong KY. Anal Chem; 2005 Aug 15; 77(16):5268-76. PubMed ID: 16097768 [Abstract] [Full Text] [Related]
19. Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli. Hiraoka M, Okamoto R, Inoue M, Mitsuhashi S. Antimicrob Agents Chemother; 1989 Mar 15; 33(3):382-6. PubMed ID: 2658786 [Abstract] [Full Text] [Related]
20. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics. Hrebenda J, Heleszko H. J Antimicrob Chemother; 1985 Aug 15; 16(2):149-56. PubMed ID: 3905746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]